Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
<p>Abstract</p> <p>Background</p> <p>Minocycline, a second-generation tetracycline with anti-inflammatory and anti-apoptotic properties, has been shown to promote therapeutic benefits in experimental stroke. However, equally compelling evidence demonstrates that the dru...
Main Authors: | Kaneko Yuji, Yu Guolong, Maki Mina, Xu Lin, Hara Koichi, Yasuhara Takao, Matsukawa Noriyuki, Ojika Kosei, Hess David C, Borlongan Cesar V |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-10-01
|
Series: | BMC Neuroscience |
Online Access: | http://www.biomedcentral.com/1471-2202/10/126 |
Similar Items
-
Transplantation of Bone Marrow-Derived Stem Cells: A Promising Therapy for Stroke
by: Yamei Tang, et al.
Published: (2007-02-01) -
Breaking out from the neuroprotective logjam: combined treatment with remote ischemic conditioning and minocycline in the prehospital setting
by: Jung Mi Park, et al.
Published: (2015-01-01) -
Article Commentary: Cell Transplantation: Stem Cells in the Spotlight
by: Cesar V. Borlongan Ph.D., et al.
Published: (2005-09-01) -
Stem Cell Transplantation for Neuroprotection in Stroke
by: Cesar V. Borlongan, et al.
Published: (2013-03-01) -
Neuroprotective effects of amiodarone in a mouse model of ischemic stroke
by: Masakazu Kotoda, et al.
Published: (2017-12-01)